MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
Matthijs van der MeulenLinda DirvenKaterina BakuninaMartin J van den BentSamar IssaJeanette K DoorduijnJacoline E C BrombergPublished in: Journal of neuro-oncology (2021)
Neurocognitive disturbances, measured with the MMSE at baseline, are an unfavorable prognostic factor for both PFS and OS in adult PCNSL patients up to 70 years-old.